How important is nonprofit journalism?

Donate by May 7 and your gift to The Center for Public Integrity will be matched dollar-for-dollar up to $15,000.

Click to donate

Analysis — Are seniors paying attention to Paul Ryan's plan for Medicare?

By Wendell Potter

ANALYSIS: Republicans sold seniors a bill of goods on health care reform and Medicare

Related to this story

OPINION: Guess who would benefit from privatizing Medicare?

By Wendell Potter

Medicare patients received expired, terminated drugs

By Joe Eaton

GAO: Almost a tenth of Medicare spending was improper

By Laurel Adams

Report faults Medicare controls on widely abused drugs

By Joe Eaton

GAO: Almost a tenth of Medicare spending was improper

By Laurel Adams

An estimated $48 billion went to improper Medicare payments last year, out of the $509 billion spent on health care for elderly and disabled

Related to this story

Analysis — Are seniors paying attention to Paul Ryan's plan for Medicare?

By Wendell Potter

Report faults Medicare controls on widely abused drugs

By Joe Eaton

OPINION: Guess who would benefit from privatizing Medicare?

By Wendell Potter

Medicare patients received expired, terminated drugs

By Joe Eaton

Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

Related to this story

States see importation as solution to high drug costs

By Victoria Kreha

Spending on lobbying thrives

By M. Asif Ismail

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Senator seeks deadline for Medicare to prevent prescription drug fraud

By Joe Eaton

Advertisement

Senator seeks deadline for Medicare to prevent prescription drug fraud

By Joe Eaton

Taxpayer-funded Medicare recently spent more than $1 billion on drug prescriptions missing a valid doctor identification number and a Senate

Related to this story

Prescription for power

By M. Asif Ismail

OPINION: Rep. Ryan's budget plan is a "Path to the Poorhouse"

By Wendell Potter

OPINION: Big Pharma's stranglehold on Washington

By Wendell Potter

Family docs not ready to leave AMA group with influence over Medicare pay

By Joe Eaton

Congressman takes swipe at program to reduce Medicare fraud

By Naseem Miller and Joe Eaton

As health reform bills consume Congress, a battle over a program designed to help cut soaring rates of Medicare overpayment and fraud is pla

Related to this story

OPINION: Rep. Ryan's budget plan is a "Path to the Poorhouse"

By Wendell Potter

GAO says Medicare regulator followed the rules in Humana smackdown

By Joe Eaton

Medicare fraud out of control

By The Center for Public Integrity

Study: Medicare contractors vulnerable to conflict

By The Associated Press

Medicare patients received expired, terminated drugs

By Joe Eaton

Medicare patients in 2006-07 likely received more than $112 million worth of expired prescription drugs or drugs that have been pulled from

Related to this story

Analysis — Are seniors paying attention to Paul Ryan's plan for Medicare?

By Wendell Potter

Report faults Medicare controls on widely abused drugs

By Joe Eaton

OPINION: Guess who would benefit from privatizing Medicare?

By Wendell Potter

GAO: Almost a tenth of Medicare spending was improper

By Laurel Adams

Advertisement

Health reform lobbyist mistakenly errs on side of transparency

By Joe Eaton

If numbers are to be trusted, longtime advertising lobbyist Jim Davidson of Polsinelli Shughart is the top dog of the 2009 health care refor

Related to this story

Commentary: Changing Washington: The hard part

By Bill Buzenberg

PhRMA's envoys

By M. Asif Ismail

Drug lobby second to none

By M. Asif Ismail

Spending on lobbying thrives

By M. Asif Ismail

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

Related to this story

Surrogates for their agenda

By Alexander Cohen

Deep pockets contribute to success

By M. Asif Ismail

Checkbook politics

By Victoria Kreha

Drug makers' dime funds Congressional travel

By Robert Brodsky

Commentary: Changing Washington: The hard part

By Bill Buzenberg

The difficulty overcoming the entrenched political tradition of earmarks is just one of many hard realities that will test the Obama Adminis

Related to this story

Health reform lobbyist mistakenly errs on side of transparency

By Joe Eaton

Drug lobby second to none

By M. Asif Ismail

Checkbook politics

By Victoria Kreha

PhRMA's envoys

By M. Asif Ismail

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Related to this story

Drug makers' dime funds Congressional travel

By Robert Brodsky

Deep pockets contribute to success

By M. Asif Ismail

Surrogates for their agenda

By Alexander Cohen

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

Pages